Protagonist Therapeutics, Inc. (PTGX)

82.78 -0.71 (-0.85%) USD  |  NASDAQ  |  Feb 12, 10:46
More

Protagonist Therapeutics EV to CFO

EV to CFO Chart

View EV to CFO for PTGX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to CFO Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EV to CFO Range, Past 5 Years

View EV to CFO Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to CFO Benchmarks

View EV to CFO Benchmarks
Start Trial
ADMA Biologics, Inc. Upgrade
Johnson & Johnson Upgrade
Glaukos Corp. Upgrade
Krystal Biotech, Inc. Upgrade
TransMedics Group, Inc. Upgrade

EV to CFO Related Metrics

EV to EBITDA Upgrade
EV to EBIT Upgrade
EV to Revenues Upgrade
EV to Free Cash Flow Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade